@article{Rayegani_Jalalian_Babaee_Hojjati_2020, title={Multifocal Neurologic Manifestation of Coronavirus Disease 2019 Infection: Report of 2 Cases}, volume={2}, url={https://jpmre.org/index.php/jpmre/article/view/46}, DOI={10.22122/pmre.v2i1.65}, abstractNote={<p><strong>Background:</strong> The most common neurological symptoms of coronavirus disease 2019 (COVID-19) were hypogeusia and hyposmia; neuropathy was recently reported in patients with COVID-19. It is not yet clear if the virus has the potential to affect the nervous system or it is just a co-incidental finding. In this study, we report 2 patients with a history of COVID-19 presenting neurological symptoms and weakness, who did not meet the Guillain‐Barre syndrome (GBS) criteria.</p> <p><strong>Case Report: </strong>The first patient was a 56-year-old man who developed flu-like symptoms and was isolated for fourteen days after being diagnosed with COVID-19 through positive polymerase chain reaction (PCR) test and lung computed tomography (CT) scan. Three weeks later, the patient developed right-sided peripheral facial palsy, four-limb paresthesia, and progressive lower limb weakness. The second patient was a 62-year-old man with more or less the same presentation as patient number 1 except for lack of facial involvement and normal lower limbs’ sensory nerve conduction study (NCS).</p> <p><strong>Conclusion:</strong> Here, we have reported 2 cases that developed neuropathic symptoms following the COVID-19 symptoms in the recovery period. The majority of the research regarding neuropathies in patients with COVID-19 studied the facial nerve involvement and GBS, and a sensory-predominant polyneuropathy is not yet reported, as far as we know. With the suspicion of an acute myelitis and sensory neuropathy, the patients were prescribed intravenous immunoglobulin (IVIg).</p>}, number={1}, journal={JPMRE}, author={Rayegani, Seyed Mansoor and Jalalian, Babak and Babaee, Marzieh and Hojjati, Fateme}, year={2020}, month={Mar.}, pages={32–34} }